SCHEMBL13058441

SCHEMBL13058441

Cc1cc(Cl)ncc1C1C(=O)[C@@H]2[C@H](C1=O)[C@H]1CC[C@@H]2O1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 1/20 0.43
▸ CHRNA4 P43681 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.32
▸ GMNN O75496 1/20 0.32
▸ PPM1B O75688 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ PPP1CC P36873 1/20 0.32
▸ TFPI2 P48307 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ PPP5C P53041 1/20 0.32
▸ PPP1CA P62136 1/20 0.32
▸ PMP22 Q01453 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ THPO P40225 1/20 0.32
▸ TAAR1 Q96RJ0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3753836 1.00 CHRNB2 (0.43) CHRNB2CHRNA4L3MBTL1KDM4EGMNN
SCHEMBL3257044 0.69 ABL1 (0.33) CHRNB2CHRNA4L3MBTL1ABL1
SCHEMBL15002006 0.69 L3MBTL1 (0.36) L3MBTL1KDM4EGMNNPPM1BLMNA
SCHEMBL2122883 0.68 L3MBTL1 (0.40) L3MBTL1KDM4EGMNNPPM1BLMNA
SCHEMBL6727885 0.68 L3MBTL1 (0.35) L3MBTL1KDM4EGMNNPPM1BLMNA
SCHEMBL18874378 0.68 L3MBTL1 (0.35) L3MBTL1KDM4EGMNNPPM1BLMNA
SCHEMBL13058455 0.67 LMNA (0.38) L3MBTL1KDM4EGMNNPPM1BLMNA
SCHEMBL13058552 0.66 NPC1 (0.39) L3MBTL1KDM4ELMNARAB9ASMN1; SMN2
SCHEMBL13058453 0.66 NPC1 (0.43) KDM4ERAB9ASMN1; SMN2
SCHEMBL13058450 0.66 L3MBTL1 (0.38) L3MBTL1KDM4EGMNNPPM1BLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188294-B1 TRICYCLIC BRIDGED CYCLOPENTANEDIONE DERIVATIVES AS HERBICIDES SYNGENTA LTD (GB) 2015-03-18 — — EP disclosed
US-8530667-B2 Herbicides SYNGENTA LIMITED (GB) 2013-09-10 — — US disclosed
US-8530667-B2 Herbicides SYNGENTA LIMITED (GB) 2013-09-10 — — US disclosed
US-20100298140-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-11-25 — — US disclosed
US-20100298140-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-11-25 — — US disclosed
WO-2009030450-A2 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2009-03-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298140-A1 NOVEL HERBICIDES DDT, CYP1B1, CYP1A1 CHRNB2 2174/4885CHRNA4 1771/4885L3MBTL1 1525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback